Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia

Blood

Volumn 89, Issue 4, 1997, Pages 1133-1142

  Choudhury, Aniruddha ^a   Gajewski, James L ^a   Liang, Jan C ^a   Popat, Uday ^a   Claxton, David F ^a   Kliche, Kay Oliver ^a   Andreeff, Michael ^a   Champlin, Richard E ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0031056587     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1133     Document Type: Article

References (20)

1. Champlin RE: Separation of graft-versus-host disease and graft-versus-leukemia effect against chronic myelogenous leukemia. Exp Hematol 23:1148, 1995
2. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringden O, Stone JAV, Bortin MM: Identical-twin bone marrow transplants for leukemia. Ann Intern Med 120:646, 1994
3. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120, 1991
4. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462, 1990
5. Steinman RM: The dendritic cell system and its role in immunogenecity. Annu Rev Immunol 9:231, 1991
6. Thomas R, Davis LS, Lipsky PE: Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol 151:6840, 1993
7. + progenitors in human bone marrow. J Immunol 149:2681, 1992
8. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994
9. Fialkow PJ, Jacobson RJ, Papayannopoulou T: Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63:125, 1977
10. Gee AP, Mansour VH, Weiler MB: Effects of target antigen density on the efficacy of immunomagnetic cell separation. J Immunol Methods 142:127, 1991
11. Klinkert WEF, LaBadie JH, O'Brien JP, Bowers WE: Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J Exp Med 156:1, 1982
12. Weidman E, Brieger J, Jahn B, Hoelzer D, Bergmann L, Mitrou PS: Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Ann Hematol 70:153, 1995
13. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor α. J Exp Med 179:1109, 1994
14. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of BCR-ABL fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:559, 1990
15. Jiang YZ, Barren AJ: Cellular and cytokine-mediated effects of CD4-positive lymphocyte lines generated in vitro against chronic myelogenous leukemia. Exp Hematol 23:1167, 1995
16. + cytotoxic T lymphocytes by dendritic cells. J Exp Med 166:182, 1987
17. + CTLs from naive precursors. J Immunol 153:996, 1994
18. Porgador A, Gilboa E: Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182:255, 1995
19. Cheever MA, Chen W, Disis ML, Takahashi M, Peace DJ: T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl. Ann NY Acad Sci 690:101, 1993
20. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thoma M, Janicel K, Anderson WF, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994